Search Results

WELL Welltower Inc. - Fundamental Analysis

NEUTRAL
WELL Stock | Fundamental Analysis & Investment Insights
NYSE Real Estate REIT - Healthcare Facilities
Current Price
$193.82
Analyst Target
$198.29
+2.3% Upside
52W High
$194.83
52W Low
$123.11

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
65%
Analysis Accuracy
Welltower Inc. (WELL) trades near its 52-week high with strong price momentum—up 46.7% over the past year and 233.5% over five years—signaling robust investor confidence. However, the stock's elevated valuation metrics, including a P/E of 133.7 and forward P/E of 106.5, are sharply disconnected from fundamentals, particularly given negative earnings growth and a concerning 189.66% dividend payout ratio. While the company has demonstrated improving quarterly earnings trends and solid revenue growth of 30.6% YoY, profitability and return metrics lag behind REIT peers. Analysts maintain a 'buy' recommendation with a $198.29 target, implying limited upside, while insider activity is neutral, offering no conviction.

Key Strengths

Exceptional revenue growth of 30.6% YoY, significantly outpacing the sector average of 7.67% and peer group (PLD: 8.7%, AMT: 7.7%, EQIX: 6.6%)
Strong recent earnings progression with 3 beats in the last 4 quarters and a 22.2% Q/Q EPS growth, indicating improving operational execution
Robust liquidity profile with a current ratio of 6.99 and quick ratio of 4.09, suggesting minimal near-term financial stress
Low leverage relative to sector peers, with a Debt/Equity ratio of 0.46 vs. sector average of 2.10, enhancing financial flexibility
Outstanding long-term price performance: +233.5% over 5 years, outperforming all listed peers (PLD: +200.3%, AMT: +11.0%, EQIX: -11.1%)

Key Risks

Extremely high valuation: P/E of 133.67 and forward P/E of 106.49, both multiples of the sector average (45.80) and lacking support from earnings growth
Negative earnings growth of -43.7% YoY and -37.6% Q/Q, raising concerns about profit sustainability despite revenue strength
Unsustainable dividend policy with a payout ratio of 189.66%, indicating dividends are being funded by sources other than earnings
Deteriorating return metrics: ROE of 2.75% and ROA of 2.00% are well below sector averages of 14.17% and 25.05% profit margin, signaling weak capital efficiency
Missing key financial data (EV, cash, debt, shares outstanding) limits transparency and raises potential governance or reporting concerns
AI Fair Value Estimate
Based on comprehensive analysis
$145.0
-25.2% below current price

Performance Snowflake

Multi-dimensional AI analysis across 5 key categories

Unlock AI-Powered Analysis

See Value, Future Performance, Past Performance, Financial Health & Dividend scores

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Unlock Price Charts

View historical price trends and analyst targets

Historical Performance Trends

Long-term financial metrics and growth patterns

Unlock Historical Data

View 3-year revenue, profit margins, and growth trends

Valuation Metrics

Key valuation ratios and pricing indicators

Sign up to view

P/E, P/B, P/S, EV/EBITDA and more

Profitability, Growth & Financial Health

Detailed profit margins, ROE, debt ratios, and liquidity metrics

Unlock Detailed Metrics

View ROE, Operating Margin, Debt/Equity, Current Ratio and more

Sector Comparison & Peer Analysis

Compare WELL against industry averages and similar companies

Unlock Sector Insights

See how WELL compares to competitors and industry standards

Insider Trading & Analyst Ratings

Track insider transactions and Wall Street analyst recommendations

Unlock Insider Data

See recent insider buys/sells and analyst price targets

See the full WELL analysis

Free signup • Unlock all metrics • No credit card required